Why Doesn’t Your Immune System Know You Have Eyes?

Why Doesn't Your Immune System Know You Have Eyes

Introduction

Your immune system is very smart. It knows about most parts of your body and protects them from germs and diseases. But there’s one part your immune system doesn’t seem to know much about – your eyes! This seems strange since your eyes are so important. Why doesn’t your immune system recognize your eyes?

Scientists have been trying to understand this mystery for a long time. Your eyes have some sneaky tricks to hide from your immune system. Understanding these tricks helps explain why your immune system acts like it doesn’t know you have eyes.

Unique Features of the Eye

To understand why your immune system doesn’t recognize your eyes, you need to know some unique facts about the eye:

No Direct Connection to the Immune System

Most parts of your body have tiny tubes called lymph vessels. These tubes connect body tissues to lymph nodes. Lymph nodes serve as gathering places for immune cells. They assist in facilitating communication between immune cells. But the eye has no direct lymph vessel connections to lymph nodes!

Tight Barriers

The eye is sealed off from the bloodstream by tight barriers. Special cells fit tightly together to form walls. Immune cells called white blood cells normally move in and out of body tissues through blood vessel walls. But the barriers around the eye make it hard for them to enter.

Calming Chemicals

The eye produces chemical signals that instruct immune cells to remain calm and composed. For example, the eye makes something called TGF-beta. This chemical changes attacking immune cells into peace-keeping cells.

In short, the eye is not directly connected to the immune system. It has protective barriers that prevent immune cells from entering, and it also produces substances that help control them. Let’s look closer at how these features fool the immune system.

Hiding Behind Walls

Do you recall the protective barriers encasing the eye that effectively obstruct immune cells? Scientists call this “sequestration” – when something is hidden away and hard to reach. Sequestration stops immune cells from seeing eye proteins that could trigger an attack. This makes the immune system ignorant about the eye.

Here’s an analogy:

Pretend there’s a castle with a big wall and closed gate. Knights inside the castle walls don’t know what’s happening in the outside villages. They stay ignorant. The same thing happens with immune cells outside the eye. The barriers keep them ignorant about what’s inside the eye.

Releasing Calming Chemicals

The eye also stays protected by releasing calming chemicals. Remember TGF-beta? This chemical changes attacking immune cells into peace-keeping cells called regulatory T cells.

Regulatory T cells stop other immune cells from attacking. It’s like they put attacking cells in “time out”! TGF-beta does this trick both inside the eye and in nearby lymph nodes. This chemical handshake from the eye calms the immune system.

Fooling the Immune System

So in summary, the eye fools the immune system using:

  • Sequestration – hiding behind barriers
  • Calming chemicals like TGF-beta

This keeps the immune system ignorant. It doesn’t know about eye proteins that could trigger an attack. The eye stays safe behind its sneaky barriers!

When the Tricks Fail

The eye’s tricks usually work to avoid attacks. But sometimes they fail, leading to trouble:

Infection

Germs like bacteria and viruses can sneak through the eye’s barriers. They trigger a strong immune reaction. This attacks the germs BUT also damages the eye. Examples are pink eye and eye ulcers.

Injury

Injuries like a scratched cornea can also break the barriers. This lets immune cells rush in and cause inflammation.

Autoimmunity

In autoimmune diseases, the immune system gets confused and attacks the body’s own tissues. Uveitis is an autoimmune disease that causes eye inflammation. Barrier breakdown and low TGF-beta levels may contribute to uveitis.

So, while the eye’s tricks usually stop attacks, they sometimes fail. A strong immune response can harm the eye. That’s why we need treatments to calm immune reactions.

Treatments to Calm Immune Attacks on the Eye

Doctors have treatments to calm an overactive immune response in the eye:

  • Steroid eye drops – Steroids reduce inflammation and calm the immune attack
  • Immunosuppressants – These drugs dampen the whole immune system
  • Antibody drugs – Specialized antibodies block specific inflammatory chemicals
  • TGF-beta eye drops – Supplying more TGF-beta could calm attacks

The eye has unique defenses to avoid immune attacks. Understanding these tricks helps researchers design better treatments when the immune system fails to respect the eye.

Conclusion

The eye has particular barriers and chemicals that hide it from the immune system. This prevents attacks but sometimes fails. Understanding the eye’s sneaky defenses gives clues to better treatment when the immune system harms the eye. So, while the immune system doesn’t seem to know you have eyes, researchers are starting to understand the eye’s secrets!

References

Hori, J. (2009). Molecular mechanisms of immune suppressive microenvironment in the cornea. Cornea28(11), S58-S64. https://doi.org/10.1097/ico.0b013e3181ae9b8b

Keino, H., Horie, S., & Sugita, S. (2018). Immune privilege and eye-derived t-regulatory cells. Journal of Immunology Research, 2018, 1-12. https://doi.org/10.1155/2018/1679197

Silver, P., Agarwal, R., Su, S., Suffia, I., Grajewski, R., Luger, D., … & Caspi, R. (2007). Hydrodynamic vaccination with dna encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory t cells. The Journal of Immunology179(8), 5146-5158. https://doi.org/10.4049/jimmunol.179.8.5146

Streilein, J. (2003). Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. Journal of Leukocyte Biology74(2), 179-185. https://doi.org/10.1189/jlb.1102574

Taylor, A. (2009). Ocular immune privilege. Eye23(10), 1885-1889. https://doi.org/10.1038/eye.2008.382